[go: up one dir, main page]

FR3104943B1 - Lipoaminoacides et leurs utilisations comme actif antipelliculaire - Google Patents

Lipoaminoacides et leurs utilisations comme actif antipelliculaire Download PDF

Info

Publication number
FR3104943B1
FR3104943B1 FR1914961A FR1914961A FR3104943B1 FR 3104943 B1 FR3104943 B1 FR 3104943B1 FR 1914961 A FR1914961 A FR 1914961A FR 1914961 A FR1914961 A FR 1914961A FR 3104943 B1 FR3104943 B1 FR 3104943B1
Authority
FR
France
Prior art keywords
lipoamino acids
dandruff active
cosmetic
prevention
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1914961A
Other languages
English (en)
Other versions
FR3104943A1 (fr
Inventor
Xavier Schultze
Sébastien Lecommandoux
Haohao Duan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
LOreal SA
Universite de Bordeaux
Institut Polytechnique de Bordeaux
Original Assignee
Centre National de la Recherche Scientifique CNRS
LOreal SA
Universite de Bordeaux
Institut Polytechnique de Bordeaux
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, LOreal SA, Universite de Bordeaux, Institut Polytechnique de Bordeaux filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR1914961A priority Critical patent/FR3104943B1/fr
Publication of FR3104943A1 publication Critical patent/FR3104943A1/fr
Application granted granted Critical
Publication of FR3104943B1 publication Critical patent/FR3104943B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/002—Preparations for repairing the hair, e.g. hair cure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

Titre : Lipoaminoacides et leurs utilisations comme actif antipelliculaire La présente invention a pour objet un composé de formule (I) ainsi que ses isomères optiques, ses tautomères et ses sels d’acide, ou de base, organiques ou minéraux : ses procédés de préparation et ses utilisations cosmétiques et pharmaceutiques dans la prévention et/ou le traitement des états pelliculaires du cuir chevelu associés ou non à un désordre dermatologique ainsi que dans la prévention et/ou le traitement de la dermite séborrhéique. La présente invention concerne également les compositions cosmétiques, dermatologiques ou pharmaceutiques comprenant ledit composé de formule (I)).
FR1914961A 2019-12-19 2019-12-19 Lipoaminoacides et leurs utilisations comme actif antipelliculaire Active FR3104943B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1914961A FR3104943B1 (fr) 2019-12-19 2019-12-19 Lipoaminoacides et leurs utilisations comme actif antipelliculaire

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1914961 2019-12-19
FR1914961A FR3104943B1 (fr) 2019-12-19 2019-12-19 Lipoaminoacides et leurs utilisations comme actif antipelliculaire

Publications (2)

Publication Number Publication Date
FR3104943A1 FR3104943A1 (fr) 2021-06-25
FR3104943B1 true FR3104943B1 (fr) 2022-05-13

Family

ID=72088164

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1914961A Active FR3104943B1 (fr) 2019-12-19 2019-12-19 Lipoaminoacides et leurs utilisations comme actif antipelliculaire

Country Status (1)

Country Link
FR (1) FR3104943B1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202428269A (zh) 2022-11-21 2024-07-16 西班牙商塞提斯生物技術公司 可離子化脂質及包含其的脂質奈米顆粒
EP4371976A1 (fr) * 2022-11-21 2024-05-22 Certest Biotec, S.L. Lipides ionisables et nanoparticules lipidiques les contenant

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002634A (en) * 1969-09-04 1977-01-11 Societe Anonyme Dite: L'oreal N-oxypyridyl substituted cysteine or cysteine derivative thereof
EP1765376B1 (fr) * 2004-06-12 2013-04-10 Signum Biosciences, Inc. Compositions topiques et utilisation de celles-ci pour lutter contre des maladies epitheliales
EP3507325A2 (fr) * 2016-08-31 2019-07-10 Vyome Therapeutics Limited Composés, compositions et procédés associés à des applications antimicrobiennes

Also Published As

Publication number Publication date
FR3104943A1 (fr) 2021-06-25

Similar Documents

Publication Publication Date Title
MA55890B1 (fr) Modulateurs de thr-beta avec un groupe de tête dioxo-1,2,4-triazyl
US8058303B2 (en) Pharmaceutical composition for external use
MA35459B1 (fr) Composés et compositions pouvant être utilisés en tant qu'inhibiteurs de la kinase c-kit
US8349882B2 (en) Pharmaceutical composition for external use
MA43979B1 (fr) Dérivés de 1h-indazole-3-carboxamide et composés similaires en tant qu'inhibiteurs du facteur d pour le traitement de maladies characterisés par une activité aberrante du système complémentaire, comme p.E. Troubles immunologiques
MA33734B1 (fr) N1-pyrazolospirocétone inhibitrices d'acétyl-coa carboxylase
MA42295B1 (fr) Composés de la benzoxazépin oxazolidinone et procédé pour leur utilisation
MA45598B1 (fr) Stéroles 24-hydroxylés substitués en position 11 pour le traitement des maladies liées au récepteur nmda
MA34889B1 (fr) Dérivés de 6 - cyclobutyl - 1, 5 - dihydro - pyrazolo [3, 4-d] pyrimidin- 4 - one et leur utilisation en tant qu'inhibiteurs de pde9a
MA37762A1 (fr) Composés n-aryltriazole utilisés comme antagonistes de lpar
BR112015024678A2 (pt) inibidor da cinase
MA40955B1 (fr) 2-amino-6-(difluorométhyl)-5,5-difluoro-6-phényl-3,4,5,6-tétrahydropyridines comme inhibiteurs de bace1
FR2608045A1 (fr) Utilisation d'inhibiteurs de xanthine- oxydase, de piegeurs de radicaux libres oxygenes et de chelateurs du fer pour la fabrication d'une composition pharmaceutique destinee au traitement du glaucome et compositions pharmaceutiques destinees au traitement du glaucome
MA30260B1 (fr) Acides 4-phenyl-thiazole-5-carboxyliques et amides d'acide 4-phenyl-thiazole-5-carboxylique en tant qu'inhibiteurs de plk 1
KR20180094989A (ko) 노화 관련 인지장애 및 신경염증의 예방 및/또는 치료 방법
FR3104943B1 (fr) Lipoaminoacides et leurs utilisations comme actif antipelliculaire
MA39165A1 (fr) Dérivés de benzimidazole-proline pour leurs utilisations dans le traitement du syndrome des etats crepusculaires
MA41150B1 (fr) Polymères de liaison aux protons pour administration orale
MA31094B1 (fr) Utilisation de dérivés de pyranone-acide substituée pour le traitement du syndrome métabolique
MA37765A1 (fr) Composés de pyrazole substitués utilisés comme antagonistes de lpar
MA47082B1 (fr) Amides aromatiques d'acide carboxylique en tant qu'antagonistes des recepteurs bradykinin b1
BR112013024909A2 (pt) composto, composição farmacêutica, método para o tratamento, prevenção ou melhoria de um ou mais sintomas de desordem, doença, ou condição mediada por pi3k, e método para modular a atividade enzimática de pi3k
MA57379B1 (fr) Modulateurs du recepteur alpha associe aux oestrogenes (err-alpha)
US20180353459A1 (en) Pharmaceutical composition for treating inflammation and pain
FR3059236B1 (fr) Extraits de plantes du genre tagetes et leurs utilisations

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20210625

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7